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LETTERS TO THE EDITOR 
Computer-Simulated and Clinical Models 
Agree on Optimal Postoperative Management 
for Hypoplastic Left Heart Syndrome 
The postoperative management of children after Stage I palliation of 
hypoplastic left heart syndrome isa daunting task. The recent report by 
Barnea et al. (1) is a major contribution toward a better understanding 
of this complex physiology. In contrast to most of the accepted 
management s rategies based on experience (trial and error), the 
authors provide an elegant mathematical nalysis of how systemic 
oxygen delivery can be optimized in the face of parallel circulations. 
Earlier publications (2,3) have suggested that survival was im- 
proved when the arterial saturation was maintained in the range 75% 
to 80%, implying a pulmonary/systemic flow ratio (Qp/Q~) close to 
unity. Barnea et al. (1) showed that with little deviation in systemic 
arterial oxygen content from that "optimal range," there was a 
potential for marked variation in cardiac output, systemic oxygen 
delivery and Qp/Qs ratio. They also proved that maximal systemic 
oxygen delivery (the product of arterial oxygen content [Cao2] and Q~) 
occurred at a Qp/Qs ratio <1 for all values of cardiac output and 
pulmonary venous saturation. They suggested that clinical measure- 
ment of venous aturations would be useful, allowing one to calculate 
and optimize QJQ~. 
Our recently published report (4) described exactly that method, 
after Stage I palliation for hypoplastic left heart syndrome in 13 
patients. By assuming pulmonary venous saturation of 95%, and by 
measuring superior vena cava saturation intermittently (using a 3F 
indwelling catheter placed at operation), we were able to demonstrate 
marked abnormalities in Qp/Qs despite "optimal" systemic arterial 
saturations, exactly as predicted by the mathematical model of Barnea 
et al (1). We were then able to direct changes in the patient's 
ventilation, inotropic and vasodilator support o achieve a QJQs as 
close to unity as possible. Using this strategy, our experience in Stage 
I patients has been very rewarding, with 27 of 32 Stage I patients (84%) 
ultimately discharged home from the hospital. 
We disagreed with the last conclusion of Barnea et al. (1) that when 
both systemic arterial and systemic venous saturations are low, Qp 
should be increased. With an acceptable systemic arteriovenous oxy- 
gen difference (<25%), Q~ should also be acceptable. To intervene to 
increase Qp relative to Qs would be to "steal" flow from the systemic 
circulation. That manipulation may result in a higher arterial satura- 
tion at the expense of lower systemic oxygen delivery. The curve on 
which the authors' recommendation is based (Fig. 5) assumes a 
pulmonary vein saturation of 96% (1). Obviously, with lower pulmo- 
nary venous saturation Qp/Qs and oxygen delivery are better than the 
model would predict. At the bedside, we would have given oxygen to 
rule out pulmonary venous desaturation because we also assumed 
normal pulmonary venous saturation. 
With no response to oxygen, we would have attempted to improve 
both Qp and Qs by increasing inotropic or vasodilating agents, or both, 
before trying to selectively dilate the pulmonary circuit. 
Although both computer-simulated and clinical studies oversim- 
plify complex "whole-body" events, as Barnea et al. correctly point out 
in their conclusion (1), results of each indicate that monitoring venous 
saturations and optimizing Qp/Qs appear to be critical to outcome in 
patients with parallel circulations. 
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Reply 
Within days of acceptance of our theoretic analysis (1), we were 
pleased to see the publication by Rossi et al. (2) demonstrating the 
value of monitoring systemic mixed venous oxygen saturation after 
first-stage palliation of hypoplastic left heart syndrome. As our theo- 
retic model predicted, they showed clinically that even with large 
variations in the pulmonary/systemic ratio (QJQs), arterial oxygen 
saturation changes were minimal. In contrast, mixed venous oxygen 
saturations provided asensitive monitor of changes in Qp/Qs' Although 
both publications directed attention to hypoplastic left heart syn- 
drome, the importance of monitoring systemic mixed venous oxygen 
saturation should also be relevant to other univentricular circulations. 
We were also pleased that Rossi et al. had critically reviewed our 
report and responded with the preceding letter. The sole point of 
disagreement centers around our recommendation that when both 
systemic arterial and systemic venous aturations are low, Qp should be 
increased. Our statement was based on Figure 5 in our report and thus 
assumed that cardiac output and pulmonary venous oxygen saturation 
were constant. In our model, because oxygen availability appeared to 
peak at a Qp/Qs ratio of -0.5, our recommendation referred to 
situations where the QJQs ratio was less than this value. Although we 
recognize the concern that increasing Qp relative to Qs may "steal" 
flow from the systemic irculation, exact calculations with our model 
indicate that systemic oxygen availability would actually increase. As 
an example (from Fig. 2 in our study), with pulmonary venous oxygen 
saturation at 96% and cardiac output at 800 ml/min, increasing the 
Qp/Qs ratio from 0.25 to 0.50 increases pulmonary blood flow by 67% 
but only decreases systemic blood flow by 17%. The net effect is an 
increase in systemic oxygen availability from 63.2 to 76.6 ml/O 2 per 
rain. 
It is, of course, unrealistic to expect that cardiac output and 
pulmonary venous oxygen saturation will remain constant in a clinical 
situation. Thus, possible changes in either or both of these variables 
must be considered in interpreting systemic arterial and mixed venous 
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